General form of registration statement for all companies including face-amount certificate companies

Temporary Equity and Stockholders' Deficiency (Details Narrative)

v3.20.2
Temporary Equity and Stockholders' Deficiency (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 28, 2020
Sep. 02, 2020
Feb. 18, 2020
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Sep. 03, 2020
Dec. 31, 2017
Common stock, shares authorized       150,000,000   150,000,000   150,000,000 80,000,000 150,000,000  
Foreign currency translation adjustments       $ (17,837) $ 365,350 $ 400,686 $ 730,767 $ 710,386 $ (2,314,409)    
Options [Member]                      
Number of stock options to purchase of shares granted           1,535,000   4,489,890 2,830,000    
Share based compensation       56,413 105,178 $ 262,670 $ 331,680 $ 432,187 $ 716,249    
Employee service share-based compensation, nonvested awards, compensation not yet recognized, stock options       $ 862,823   $ 862,823   $ 1,143,412      
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition           2 years 7 months 28 days   2 years 8 months 9 days      
Number of stock options outstanding       9,209,586   9,209,586   9,550,640 9,499,265   9,234,265
2018 Plan [Member]                      
Number of stock options to purchase of shares granted 1,535,000                    
Options exercise price $ 0.605                    
Vesting percentage 25.00%                    
Stock option vesting period 3 years                    
Number of stock option granted, value $ 263,642                    
Weighted average estimated fair value of the stock options granted           $ 0.17 $ 0.13        
2018 GGI Options [Member]                      
Number of stock options to purchase of shares granted               6,595,000      
Number of stock options outstanding       2,280,000   2,280,000          
One Year Warrant [Member]                      
Number of warrants to purchase common stock       7,653,276   7,653,276          
Exercise price of warrants       $ 0.34   $ 0.34          
Series B Preferred Stock [Member]                      
Shares issued, price per share       $ 10   $ 10     $ 10.00    
Cumulative cash dividends annual rate           8.00%          
Dividends earned       $ 181,281 $ 181,746 $ 540,217 $ 539,311        
Dividends payable       $ 82,772   82,772          
Preferred stock, amount of cumulative dividends in arrears           $ 1,804,578   $ 1,264,361 $ 546,355    
Investors [Member]                      
Number of shares issued   3,706,805       413,530          
Number of shares issued for sales       3,532,941   3,532,941          
Number of shares issued for sales, value       $ 1,201,200   $ 1,201,200          
Number of shares issued, value           $ 140,600          
Shareholder [Member] | Series B Preferred Stock [Member]                      
Number of shares repurchased     1,600                
Shares issued, price per share     $ 10                
Payment of accrued dividends     $ 2,451                
Employees [Member]                      
Number of stock options to purchase of shares granted 1,135,000                    
Board of Directors [Member]                      
Dividends earned                 $ 474,719    
Number of stock options to purchase of shares granted 300,000                    
Consultants [Member]                      
Number of stock options to purchase of shares granted 100,000